Pharmacologic Management of Eosinophilic Esophagitis
Immunology and Allergy Clinics of North America · 2024-05 · 44 (2) · 245-264
DOI: 10.1016/j.iac.2023.12.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2024-05. Verfasst von Gary W Falk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania Perelman Sc…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Enteritis, Eosinophilia, Gastritis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 93 Literaturangaben.
Abstract (Originalsprache)
Proton pump inhibitors (PPIs), swallowed topical corticosteroids (STSs), and dupilumab are highly effective therapies for the treatment of eosinophilic esophagitis. Shared decision-making informs the choice of therapy and factors such as ease of use, safety, cost, and efficacy should be addressed. PPIs are the most common medication utilized early in the disease course; however, for nonresponders, STSs are an excellent alternative. Dupilumab is unlikely to replace PPIs or STSs as first-line therapy, except in highly specific circumstances. Identification of novel biologic pathways and the development of small molecules may lead to a wider range of treatment options in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology & Hepatology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, 7th Floor South Pavilion PCAM, 3400 Civic Center Bou…
- Division of Allergy and Immunology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, 13 Children's Way, Slot 512-13, Little Rock, AR 72202, USA. Electronic address: rd…
Zitieren
APA
Falk, G. W., & Pesek, R. (2024). Pharmacologic Management of Eosinophilic Esophagitis. Immunology and Allergy Clinics of North America, 44(2), 245-264. https://doi.org/10.1016/j.iac.2023.12.010
Vancouver
Falk GW, Pesek R. Pharmacologic Management of Eosinophilic Esophagitis. Immunology and Allergy Clinics of North America. 2024;44(2):245-264. doi:10.1016/j.iac.2023.12.010
BibTeX
@article{Falk2024,
author = {Falk, Gary W and Pesek, Robbie},
title = {Pharmacologic Management of Eosinophilic Esophagitis},
journal = {Immunology and Allergy Clinics of North America},
year = {2024},
volume = {44},
number = {2},
pages = {245--264},
doi = {10.1016/j.iac.2023.12.010}
}
EUVIMED